$AMPE Recent Headlines Friday’s biggest gaining and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2013 at 8:46 PM

$AMPE Recent Headlines

Friday’s biggest gaining and declining stocks 3:26 p.m. July 13, 2012 - MarketWatch
Stocks to watch Friday: Lexmark, New York & Co. 5:47 a.m. July 13, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:50 p.m. June 11, 2012 - MarketWatch
Ampio: Optina has potential for diabetic treatment 11:46 a.m. June 11, 2012 - MarketWatch.com
Ampio shares add 27% after positive trial results 6:26 a.m. June 11, 2012 - Greg Morcroft
Tuesday’s biggest gaining and declining stocks 12:50 p.m. March 20, 2012 - Kate Gibson
Ampio rallies on eye-drug study 11:52 a.m. March 19, 2012 - Val Brickates Kennedy
Ampio tumbles on stock placement 2:50 p.m. Dec. 21, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 4:38 p.m. Dec. 19, 2011 - Greg Morcroft
Ampio Pharmaceuticals tumbles on drug concerns 2:57 p.m. Dec. 15, 2011 - Val Brickates Kennedy

Cramer's Lightning Round - The Andersons Must Be Doing Something Right (11/13/13) 6:18 a.m. Nov. 14, 2013 - Seeking Alpha
'Mad Money' Lightning Round: Tired of Union Pacific 6:00 a.m. Nov. 14, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Bears Overwhelmed 8:17 p.m. Nov. 13, 2013 - TheStreet.com
Ampio AWOL With Knee-Pain Drug Data Disclosures 7:00 a.m. Nov. 12, 2013 - TheStreet.com
Ampio Pharma Announces Results from Panel Review of the Interim Analysis of the Optina(TM) Trial, FDA Agrees to 505(B) 2 Pathway 6:07 a.m. Oct. 7, 2013 - benzinga.com
Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial 6:09 a.m. Sept. 30, 2013 - benzinga.com
Ampio Momentum Continues After Positive Initial Phase III Data 2:57 p.m. Aug. 26, 2013 - Seeking Alpha
Strong Phase III Ampion Data Released Wednesday: Setting The Stage For Ampio 7:12 a.m. Aug. 15, 2013 - Seeking Alpha
10-Q: AMPIO PHARMACEUTICALS, INC. 4:06 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Raghuram 'Ram' Selvaraju On The Best Biotech Ideas Of 2013 7:20 a.m. July 22, 2013 - Seeking Alpha
What The Snubbing Of Hyaluronic Acid By The AAOS Means For Investors 8:41 a.m. June 25, 2013 - Seeking Alpha
Ampio Pharma's Luoxis Diagnostics Reports Positive Results from First Study of Proprietary Diagnostic Platform 6:06 a.m. June 20, 2013 - benzinga.com
Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way 3:53 p.m. June 6, 2013 - Seeking Alpha
2 Potentially Explosive Small Cap Stocks For 2013 3:53 a.m. May 30, 2013 - Seeking Alpha
Regeneron Shareholders Watching Optina Trial Closely 2:56 p.m. May 22, 2013 - Seeking Alpha
10-Q: AMPIO PHARMACEUTICALS, INC. 4:04 p.m. May 3, 2013 - Edgar Online - (EDG = 10Q, 10K)
Ampio Pharma Initiates Phase III, Investors Extend Momentum 8:39 a.m. May 3, 2013 - Seeking Alpha
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee 6:03 a.m. April 25, 2013 - benzinga.com
Lucrative AMD And DME Markets Attract Wall Street To Regeneron And Other Players 12:43 p.m. April 3, 2013 - Seeking Alpha
Ampio Receives FDA Acceptance for Clinical Trial of Ampion for Treatment of Osteoarthritis of the Knee 4:05 a.m. April 2, 2013 - benzinga.com

AMPIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ampio Pharmaceuticals, Inc. 5:54 p.m. Today - PR Newswire
Ampio Pharmaceuticals to Present at Upcoming Investor Conference 8:00 a.m. Nov. 15, 2013 - PR Newswire
Ampio Pharmaceuticals Reports Positive Results in the Extended Spring study of Osteoarthritis of the Knee Following a Single Intra-articular Injection of Ampion(TM) 8:00 a.m. Nov. 4, 2013 - PR Newswire
Ampio Pharmaceuticals, Inc. States that its Policy is Not to Comment on Unusual Market Activity 7:00 a.m. Oct. 25, 2013 - PR Newswire
Emerging Growth Equities, Ltd. Initiates Coverage Of Ampio Pharmaceuticals, Inc. (AMPE) With A BUY Rating And $14.00 Price Target 9:21 a.m. Oct. 11, 2013 - PR Newswire
Ampio Pharmaceuticals, Inc. Announces Positive Results from Independent Panel Review of the Interim Analysis of the Optina(TM) Trial for Diabetic Macular Edema 7:00 a.m. Oct. 7, 2013 - PR Newswire
Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platform 7:00 a.m. Oct. 1, 2013 - PR Newswire
Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial 7:00 a.m. Sept. 30, 2013 - PR Newswire
Ampio Pharmaceuticals, Inc. Announces $25 Million Financing 5:00 a.m. Sept. 26, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on AMPE, BIOS, MM and XONE 7:31 a.m. Aug. 15, 2013 - ACCESSWIRE
Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial 7:00 a.m. Aug. 14, 2013 - PR Newswire
Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog 7:00 a.m. June 7, 2013 - PR Newswire
Ampio Pharmaceuticals to List on the NYSE MKT 7:00 a.m. June 6, 2013 - PR Newswire
Ampio Pharmaceuticals Provides Clinical Updates 7:00 a.m. June 3, 2013 - PR Newswire
Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare Conference 7:00 a.m. May 13, 2013 - PR Newswire
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee 7:00 a.m. April 25, 2013 - PR Newswire
Ampio Receives FDA Clearance to Initiate Clinical Trial of Ampion(TM) for the Treatment of Osteoarthritis of the Knee: Patient Treatments have begun. 3:00 a.m. April 2, 2013 - PR Newswire
Ampio Receives FDA Acceptance of its Patient Outcome for Premature Ejaculation (POPE) Questionnaire, Paving the Way for its US Pivotal Trial on Zertane(TM) 3:00 a.m. March 11, 2013 - PR Newswire
LifeSci Advisors Initiates Coverage of Ampio Pharmaceuticals 8:02 a.m. March 7, 2013 - Marketwire
Ampio Pharmaceuticals Initiates Clinical Trial of Optina(TM) in Diabetic Macular Edema (DME): First Patient Dosed 4:00 a.m. Feb. 27, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ouma Connect Streamlines Surrogacy Medical Clearance

A Game Changer for Surrogacy Agencies When we talk about innovation, we often focus on the flashiest tech in finance or the buzz of a scorching hot stock. But here's Ouma Health, shifting gears in a sector many traders don't blink at—surrogacy. They're unveiling Ouma Connect, a portal pulling back the curtain on medical clearances for gestational-carrier candidates....

Boscia's Future Ties Tradition and Modern Science

Reviving a Skincare Legacy With the wind of innovation at its back, The Center Brands and Dr. Mamina Turegano are stepping in to breathe new life into Boscia. Now, I'm not just talking about a simple facelift. We're talking about an all-out integration of traditional Japanese skincare principles with the sharp edge of modern dermatologic science. It's a brave move...

HONOR X9e Pro Unveils with Massive Battery Power

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...

Sirha Lyon® 2027: A New Chapter in Foodservice

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Canton Fair: More Than Trade—A Cultural Exchange

Why a Trade Fair Needs Lion Dances October 2026 marks a time when talking about a trade fair means diving headfirst into a whirlpool of global exchange and cultural tango we don’t often see in the West. Yeah, I'm looking at you, Canton Fair—a long-runner over in China that's managed to haul in the globe to not just showcase wares, but bring people together in a clash...

Ademi LLP Questions RRC Buyout Deal's Fairness

Unease Surrounds RRC's Potential Acquisition by EQT Let’s talk about a messy situation brewing with Range Resources Corporation (NYSE: RRC). The lawyers at Ademi LLP are poking around in the shadows of a proposed buyout by EQT Corporation, questioning whether the deal is legit—or if someone’s getting the short end of the stick. It’s all happening in a climate...

HDD vs SSD: EaseUS Report Shows Alarming Disk Health Trends

Disks Under the Microscope: Key Insights from 2026 Report Well, here's a data nugget that'll make you rethink your storage options: EaseUS Software dropped a disk health bombshell with their 2026 report, putting HDDs in the hot seat. Turns out, HDDs are about as trustworthy as a flaky friend, clocking in at 20 times more caution or bad health ratings compared to their...

Federal Law Shifts Landscape for Manufactured Housing

Federal Act Aims to Boost Manufactured Homes Price tags on homes need a reality check, and for a long time, manufactured housing has been in the corner looking for a chance to throw its hat in the ring. Enter the 21st Century ROAD to Housing Act, aiming to finally unlock the potential sitting in our backyards when it comes to these factory-built options. We're talking...

Redwood and SAP Partner on Secure File Transfer

Redwood Advances SAP Interiors with New File Solution October 26, '26 is now a landmark for Redwood Software. They've just rolled out their SAP Managed File Transfer solution. Got the brainpower behind Redwood and SAP operating together here, and they're offering this to enterprises aimed at optimizing their file-based workflow. If you're scratching your head just hearing...

Key Sewer Line Damage Signs Homeowners Often Ignore

Spotting Trouble Beneath the Surface Now, when was the last time you eyeballed your home’s plumbing with more than a passing glance? Most folks don’t give their sewer lines two thoughts until something foul pops up. Plumbing expert Jessica Gerdeman from Heggemann, Inc. in Warrenton, Missouri, isn’t just blowing hot air when she points out the indicators of looming...